Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2B | P29275 | 8/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.72 |
| ▸ | LMNA | P02545 | 3/20 | 0.68 |
| ▸ | MEN1 | O00255 | 1/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.67 |
| ▸ | MAPT | P10636 | 1/20 | 0.64 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.63 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acefylline SCHEMBL18191994 | 1.00 | ADORA2B (1.00) | ADORA2BSMN1; SMN2LMNAMEN1KMT2A | |
| Acefylline SCHEMBL8402147 | 0.98 | ADORA2B (0.97) | ADORA2BSMN1; SMN2LMNAMEN1KMT2A | |
| Acefylline SCHEMBL1173152 | 0.94 | ADORA2B (0.89) | ADORA2BSMN1; SMN2LMNAMEN1KMT2A | |
| Acefylline SCHEMBL356114 | 0.92 | ADORA2B (0.85) | ADORA2BSMN1; SMN2LMNAMEN1KMT2A | |
| Acefylline SCHEMBL5493561 | 0.92 | ADORA2B (0.85) | ADORA2BSMN1; SMN2LMNAMEN1KMT2A | |
| Acefylline SCHEMBL17204841 | 0.92 | ADORA2B (0.84) | ADORA2BSMN1; SMN2LMNAMEN1KMT2A | |
| SCHEMBL17163939 | 0.88 | ADORA2B (0.78) | ADORA2BSMN1; SMN2LMNAMEN1KMT2A | |
| SCHEMBL11531219 | 0.88 | ADORA2B (0.78) | ADORA2BSMN1; SMN2LMNAMEN1KMT2A | |
| SCHEMBL9296212 | 0.87 | ADORA2B (0.76) | ADORA2BSMN1; SMN2LMNAKMT2AMAPT | |
| SCHEMBL5468564 | 0.87 | ADORA2B (0.76) | ADORA2BSMN1; SMN2LMNAMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1592 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025082655-A1 | LOW WATER CONTENT W/O EMULSION COMPRISING A HYDROPHOBIC FILM-FORMING POLYMER, A LINEAR SILICONE POLYOL, HYALURONIC ACID, A VITAMIN B3 AND A XANTHINE BASE | L'OREAL (FR) | 2025-04-24 | — | — | WO | claimed |
| US-12128121-B2 | Compositions comprising organo-silanol compounds, and applications | EXSYMOL (MC) | 2024-10-29 | — | — | US | claimed |
| EP-4153603-B1 | COMPOSITIONS COMPRISING ORGANO-SILANOL COMPOUNDS, AND APPLICATIONS | EXSYMOL SA (MC) | 2023-11-01 | — | — | EP | claimed |
| US-20230181444-A1 | COMPOSITIONS COMPRISING ORGANO-SILANOL COMPOUNDS, AND APPLICATIONS | EXSYMOL (MC) | 2023-06-15 | — | — | US | claimed |
| EP-4178948-A2 | FUNCTIONALIZED ISONITRILES AND PRODUCTS, PREPARATION AND USES THEREOF | Universidade de Santiago de Compostela (ES) | 2023-05-17 | — | — | EP | claimed |
| EP-4153603-A1 | COMPOSITIONS COMPRISING ORGANO-SILANOL COMPOUNDS, AND APPLICATIONS | Exsymol (MC) | 2023-03-29 | — | — | EP | claimed |
| CN-115275019-A | Perovskite solar cell and preparation method thereof | 宣城先进光伏技术有限公司 | 2022-11-01 | — | — | CN | claimed |
| CN-110974891-B | Microneedle patch for losing weight and preparation method thereof | 广州新济薇娜生物科技有限公司 | 2022-10-04 | — | — | CN | claimed |
| US-20220184052-A1 | COMPOSITION COMPRISING FEXOFENADINE | CELLIX BIO PRIVATE LIMITED (IN) | 2022-06-16 | — | — | US | claimed |
| WO-2022123511-A1 | A COMPOSITION COMPRISING FEXOFENADINE | CELLIX BIO PRIVATE LIMITED (IN) | 2022-06-16 | — | — | WO | claimed |
| WO-2000048636-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2000-08-24 | — | — | WO | claimed |
| EP-0640342-A2 | Pentoxifylline and/or depogen for improving the tissue antioxidant status | CHINOIN Gyogyszer és Vegyészeti Termékek Gyára RT. (HU) | 1995-03-01 | — | — | EP | claimed |
| EP-0072286-B2 | ORGANIC AMIDE COMPOUNDS DERIVED FROM NITROGENOUS LIPIDS | FIDIA S.p.A. (IT) | 1992-12-09 | — | — | EP | claimed |
| EP-0172383-B1 | PHARMACOLOGICALLY ACTIVE SALT DERIVATIVES OF 1,2,3,6-TETRAHYDRO-1,3-DIMETHYL-2,6 DIOXOPURINE-7-ACETIC ACID | LABORATORIO ITALIANO BIOCHIMICO FARMACEUTICO LISAPHARMA S.P.A. (IT) | 1992-02-05 | — | — | EP | claimed |
| US-4820838-A | Process for the preparation of depogen | CHINOIN GYOGYSZER- ES VEGYESZETI TERMEKEK GYARA RT. (HU) | 1989-04-11 | — | — | US | claimed |
| US-4654331-A | Oral absorption enhancement of carboxylic acid pharmaceuticals using (5-alkyl-2-oxo-1,3-dioxolen-4-yl)methyl ester group | MERCK & CO., INC. (US) | 1987-03-31 | — | — | US | claimed |
| EP-0072286-B1 | ORGANIC AMIDE COMPOUNDS DERIVED FROM NITROGENOUS LIPIDS | FIDIA S.p.A. (IT) | 1986-10-29 | — | — | EP | claimed |
| US-4514404-A | ANTITUSSIVE AGENTS | PRODES, S.A. (ES) | 1985-04-30 | — | — | US | claimed |
| EP-0051278-A1 | Soft tertiary amine esters of bio-affecting carboxylic acids, processes for preparing and a pharmaceutical composition containing the same | MERCK & CO. INC. (US) | 1982-05-12 | — | — | EP | claimed |
| US-4071517-A | Soluble salts containing sulphur | DUFOUR CLAUDE | 1978-01-31 | — | — | US | claimed |